Impax Asset Management Group PLC Organon & Co. Transaction History

Impax Asset Management Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$21.42 - $32.08 $3.89 Million - $5.83 Million	-181,795 Reduced 11.67%	1,375,396 $32.3 Million
Q4 2022 Feb 09, 2023	BUY	$23.31 - $28.61 $17.5 Million - $21.4 Million	749,215 Added 92.73%	1,557,191 $43.5 Million
Q3 2022 Nov 08, 2022	BUY	$23.4 - $34.25 $6.38 Million - $9.34 Million	272,706 Added 50.95%	807,976 $18.9 Million
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $5.96 Million - $7.33 Million	-188,312 Reduced 26.02%	535,270 $18.1 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $5.7 Million - $7.37 Million	-187,222 Reduced 20.56%	723,582 $25.3 Million
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $5.46 Million - $7.08 Million	190,559 Added 26.46%	910,804 $27.7 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $7.62 Million - $9.48 Million	266,000 Added 58.56%	720,245 $23.6 Million
Q2 2021 Aug 05, 2021	BUY	$28.45 - $38.0 $12.9 Million - $17.3 Million	454,245 New	454,245 $13.7 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.